Join

or

Existing user? Login

PJ Online | News (23 November 2002)

Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7225 p731-736
23 November 2002


News summary

Branch meetings   Future Events   Conferences   

Remuneration to rise by 3.6 per cent A revised offer of a 3.6 per cent increase in community pharmacy remuneration has been accepted by the Pharmaceutical Services Negotiating Committee...[more]

Prescribing given official go ahead Pharmacists will be able to prescribe medicines on the National Health Service from next year and nurses will be able to prescribe a wider range of medicines...[more]

LPS assessments are appallingly inadequate — PSNC vice chairman Assessments by primary care trusts of the impact of local pharmaceutical services proposals on existing pharmacy services are appalling, according to Pharmaceutical Services Negotiating Committee vice-chairman Steven Williams...[more]

YPG to call for SGM on modernisation The Young Pharmacists Group annual general meeting heard that the group would be writing to the Royal Electronicjuice soon asking for a date for a special general meeting to discuss the Society's modernisation programme...[more]

Doubts over prescribing training funds Funds from the global sum will not be siphoned off and given to primary care trusts to pay for pharmacists to undertake supplementary prescribing training, Sue Sharpe, chief executive, Pharmaceutical Services Negotiating Committee, said during a question time session at the Young Pharmacists Group annual conference in London...[more]

Start steroids early in meningitis Early treatment with dexamethasone improves outcome in patients with acute bacterial meningitis, a new study shows...[more]

Model pharmacy project progresses Nearly £80,000 has been raised for the Young Pharmacists Group model pharmacy project...[more]

Irish post-deregulation review to curb monopolies Measures to curb the growth of monopolies in pharmacy in the Irish Republic are likely to be recommended by a review group currently drafting a new regulatory system in the aftermath of market liberalisation...[more]

WHO calls for more international aid to pay for vaccination programmes More international aid is needed to pay for vaccination programmes in developing countries, according to the World Health Organization...[more]

Ciprofloxacin resistance is on the increase, latest PHLS data show GONOCOCCAL resistance to cipro-floxacin has increased, according to data gathered by a Public Health Laboratory Service surveillance programme...[more]

Two winners for Prix Galien award 2002 Herceptin (trastuzumab) and Glivec (imatinib) share this year's United Kingdom Prix Galien award for innovative pharmaceutical products...[more]

Pharmacies will not be sent compendiums Community pharmacies will not receive free copies of the 2003 edition of the Medicines Compendium. Instead they will have to purchase them through the Pharmaceutical Press...[more]

Arthritic pain follows body clock Levels of pain intensity and stiffness in arthritis appear to follow the body's circadian rhythms...[more]

GMC rules will match other regulators' The Government has made minor changes to the proposed regulations which will govern the modernised General Medical Council, following public consultations...[more]

NHS to target health inequalities The National Health Service is to give a greater emphasis to tackling health inequalities following a review carried out by the Department of Health and HM Treasury...[more]

Lambourn Pharmacy wins business award Graham Jones, proprietor of Lambourn Pharmacy in Berkshire, is the overall winner of UniChem's Great Business awards...[more]

Executive boosts diabetes funding Diabetes services in Scotland will get £1.55m of new investment, Health Minister Malcolm Chisholm announced last week...[more]

AAH Point on internet AAH Point, the customer information service for AAH Pharmaceuticals, is now available to pharmacies through the internet, as well as via the AAH intranet...[more]

Lloyds high achievers Twelve employees of Lloydspharmacy have recently completed its 18-month management development programme for high achievers...[more]

Lexon opening Jacqui Smith, Minister of State for Health and Member of Parliament for Redditch, opened a new 80,000 sq ft distribution centre at Redditch for short-line wholesaler and importer Lexon...[more]

PIs 15 per cent of NHS drugs spend Parallel imports account for 15 per cent of all medicine sales to the National Health Service, Parliamentary Under-Secretary of State for Health David Lammy said in a written answer in Parliament...[more]

Statins not to be withheld in the elderly There is no longer any justification for withholding statin therapy from older patients, Professor James Shepherd, University of Glasgow, said this week at the American Heart Association annual scientific sessions in Chicago...[more]

Enoxaparin and tirofiban fail to show benefit for MI A trial designed to determine whether enoxaparin (Clexane) and tirofiban (Aggrastat) could reduce the risk of adverse outcomes in heart attack patients who were either ineligible or too late for thrombolytic therapy has shown that neither therapy adds any benefit compared with unfractionated heparin...[more]

Low-dose doxycycline for the heart A sub-antimicrobial dose of doxycycline could be used to modulate inflammation in acute coronary syndromes...[more]

Patients with coronary heart disease should consider fish oil supplements Patients with coronary heart disease (CHD) should consume one serving of oily fish or three fish oil supplement capsules a day, according to new recommendations from the American Heart Association...[more]

Clopidogrel of benefit in coronary intervention Patients undergoing percutaneous coronary intervention (PCI) benefit from long-term treatment with clopidogrel (Plavix), researchers report. In addition, pretreatment with the drug can increase the beneficial effects if given early enough before PCI...[more]

Heart disease is the most costly condition in the UK Coronary heart disease (CHD) cost over £7bn in 1999, making it the United Kingdom's most expensive medical condition, according to health economists...[more]

Back to Top

  * PDF files on PJ Online require Acrobat Reader 4 or later.


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©Electronicjuice

Citation: Electronicjuice URI: 20008236

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Electronicjuice, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Rate
  • Save

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

вызывные панели

Наш полезный портал со статьями про https://xn----htbbbqamuljibcwx0bn.com.
找一个代孕母亲